Tariffs – Is IVD OK?

Company Q1 Investor Calls: Most IVD companies have downplayed tariff impact. Small % of revenues affected. Most emphasizing the industry’s having the most advanced supply chains in global industry, one that can shift as tariff targets change. 2 Major Trade Associations: Tariffs are damaging and we need a medical exemption. IVD Industry Blogger:

Read More »

In Vitro Diagnostics Stocks, 2025 Flu Season, Diasorin Reports

How are IVD stocks doing in the general market fall? About that huge flu season. A mid-size player reports, which (can be) a measure of the growthiness of the market. And Roche adheres its blood test to its IT-IVD product to aid interpreting results. DiaSorin Reports – Overall Growth, China VP Concerns, Not

Read More »

Clinical Laboratory Market Nears $400 Billion: Report

The market for clinical lab services is $396 billion, per a report from our partner Howe Sound Global Clinical Medical Laboratory Services Market – Eye On IVD As the healthcare landscape continues to evolve, the In Vitro Diagnostic industry is poised for significant growth, driven by advancements in biotechnology, including Artificial Intelligence. Knowledge

Read More »

We Cover IVD

Order the Most Comprehensive Report on AI in IVD

  • Over 300 pages.
  • Updated twice a year

  • Smart In Vitro Diagnostics
    Finally: A Realistic Look at the Potential for AI in IVD. With Predictions, Analysis and Vetted Numbers.
    EYE ON IVD's Recently Published Report on the Infectious Disease IVD Market Offers Superior Coverage. Hundreds of Datapoints. Markets by Country, Disease and Product Type.


    All EYE ON IVD News Stories